Kent J. Weinhold

Duke University — United States

Immunology and Microbiology · Life Sciences

61h-index15.3kcitations295works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(117), Immune Cell Function and Interaction(87), Cancer Immunotherapy and Biomarkers(63), Immunotherapy and Immune Responses(60), Cytomegalovirus and herpesvirus research(41)

Publications295 total

Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032
2025Open Access
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): conventional and distribution-based immune profiling of the tumor microenvironment and peripheral circulation
Journal for ImmunoTherapy of Cancer·2025Open Access
OS04.3.A P30-EPS PEPTIDE VACCINE IS SAFE AND IMMUNOGENIC IN NEWLY DIAGNOSED GLIOBLASTOMA: A PHASE 1B TRIAL
Neuro-Oncology·2025Open Access
Abstract P1-02-16: Matched pair single-cell RNA-sequencing highlights the impact of abemaciclib and endocrine therapy on different myeloid cell populations in advanced ER+/HER2- breast cancer
Clinical Cancer Research·2025
Abstract CT057: Evaluation of tumor associated P30-peptide antigen (ETAPA): Safety and immunogenicity in a phase 1b trial in glioblastoma
Cancer Research·2025
Abstract No. 47 Novel Method for Assessing Tumor Humoral Responses After Image-Guided Percutaneous Treatments
Journal of Vascular and Interventional Radiology·2025
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
Journal for ImmunoTherapy of Cancer·2025· 3 citedOpen Access
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
The Lancet·2024· 54 citedOpen Access
863 Characterization of tumor-infiltrating plasma cells in patients with NSCLC treated with neoadjuvant pembrolizumab
Regular and Young Investigator Award Abstracts·2024Open Access
Differences in microenvironment of lung cancer and pleural effusions by single-cell RNA sequencing
Lung Cancer·2024· 4 cited
The immunomodulatory impacts of endocrine therapy on host immunity in early-stage hormone receptor positive, HER2 negative breast cancer.
Journal of Clinical Oncology·2024· 1 cited
Differences in Microenvironment of Lung Cancer and Pleural Effusions by Single-cell RNA Sequencing
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Correlation of single-cell cytokine secretion with clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with capecitabine (C), bevacizumab (B), ± atezolizumab (A).
Journal of Clinical Oncology·2023
Evaluation of host cellular responses to Epstein–Barr virus (EBV) in adult lung transplant patients with EBV‐associated diseases
Journal of Medical Virology·2023· 2 citedOpen Access
Table S2 from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma
2023Open Access
Figure S2 from Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab
2023Open Access
Figure S1 from Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab
2023Open Access
Data from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
2023Open Access
Supplementary Figure 1 from Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells
2023Open Access
Table S2 from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma
2023Open Access
page 1 of 15Next →

Frequent Co-authors

Thomas J. Matthews(12), Dani P. Bolognesi(10), Guido Ferrari(9), David C. Montefiori(9), A J Langlois(8), Georgia D. Tomaras(8), Barney S. Graham(7), Geoffrey J. Gorse(7), Michael C. Keefer(7), Mark J. Mulligan(7), Lawrence Corey(6), Barton F. Haynes(5), George M. Shaw(5), Mario Roederer(5), M. Juliana McElrath(5), H. Kim Lyerly(5), David H. Schwartz(5), Robert B. Belshe(5), Michael Greenberg(4), Barton F. Haynes(4)